Australia Stock Exchange release from BIOXYNE : Quarterly Activities/Appendix 4C Cash Flow Report
30/01/2022 21:52
Australia Stock Exchange release from BIOXYNE BXN.AX : Quarterly Activities/Appendix 4C Cash Flow Report
Recent news on BLS Pharmaceuticals
See all newsBrief: Bioxyne Secures A$50M Exclusive German Supply Agreement With Adrex
Australia's Bioxyne rises to near 8-year high after company secures German supply deal
Australia's Bioxyne at two-week high on supply deal with Remidose LATAM
Brief: Bioxyne Expands LATAM Footprint First Supply Agreement Costa Rica
Australia's Bioxyne hits nearly 8-year high on cannabis firm deal